Myeloma.org

Multiple Myeloma Information Booklets Int Myeloma Fn

The IMF’s Understanding series of multiple myeloma cancer information booklets is designed to acquaint you with specific myeloma-related tests, treatments and therapies, supportive care measures, and common adverse events.

Actived: 9 days ago

URL: https://www.myeloma.org/cancer-information-series

Myeloma Cancer Advocacy Center Int'l Myeloma …

The IMF's multiple myeloma cancer advocacy group helps guide individuals to advocate for critical health issues that affect the multiple myeloma community. Whether you are a patient, caregiver, doctor, nurse, or friend, your opinion does matter. The only way we can make a difference is to TAKE ACTION! Become an Advocate Today.

Category:  Cancer Go Health

International Cancer Organizations & Resources

The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. National Center for Biotechnology Information The National Center for Biotechnology Information (NCBI) advances science and health by providing access to biomedical and genomic information.

Category:  Cancer Go Health

Blood Cancer Awareness Month International Myeloma

This Blood Cancer Awareness Month, the IMF’s goal is to reach people who may not have heard of myeloma and raise awareness of the disease. We invite you to educate those within your community by sharing myeloma facts, scientific innovations in myeloma treatment, and inspirational stories of those living with the disease.

Category:  Cancer Go Health

Housing and Travel Assistance for Cancer Patients The IMF

The American Cancer Society, in a cooperative effort with hotels across the country, provides overnight accommodations to cancer patients who must travel for outpatient treatment and need assistance with lodging. PALS - Patient AirLift Services. Free air transportation based on need using a …

Category:  Cancer Go Health

Toxic Chemicals and Cancer Int'l Myeloma Foundation

Toxic chemicals are toxic and can cause cancer. This week reports in two highly respected medical journals—the Lancet and the New England Journal of Medicine —agree that weed killers used with genetically modified crops (commonly known as GMOs), such as corn and soybeans, cause cancer. These reports arrive amidst a controversy that has

Category:  Cancer Go Health

Miles for Myeloma 2021

A cancer of the bone marrow plasma cells. Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with "myeloma" and "plasma cell myeloma." Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell.

Category:  Cancer Go Health

Toxic chemicals are toxic … and can cause cancer

Toxic chemicals are toxic … and can cause cancer. This week, reports in two highly respected medical journals—the Lancet and the New England Journal of Medicine —agree that weed killers used with genetically modified crops (commonly known as GMOs), such as corn and soybeans, cause cancer. These reports arrive amidst a controversy that has

Category:  Cancer Go Health

Is it the end of the American diet

So yes, cancer-causing factors are involved (and they can definitely cause cancer), but the relative risk, comparatively speaking, is low versus other chemical exposures. The chemicals involved are of two broad types. The first is heme. Red meat of all types include heme (the heme of hemoglobin—blood).

Category:  Cancer Go Health

PMMNG Home Philadelphia

Meeting notices spread throughout the Philadelphia region and relationships with local cancer organizations were established. In 1999, the growing group found its current home at the Ralston House. The membership list grew to upwards of 300 members. At present, the PMMNG is affiliated with the International Myeloma Foundation (IMF).

Category:  Cancer Go Health

Myeloma Cancer Questions FAQ International Myeloma

Review this FAQ page for answers to frequently asked questions about multiple myeloma cancer and the International Myeloma Foundation. What is multiple myeloma? How common is myeloma? Multiple myeloma is the second most common blood cancer. According to the National Cancer Institute (NCI) SEER data, an estimated new 30,770 new multiple myeloma cases have been …

Category:  Cancer Go Health

IMF Blood Cancer Awareness 2021 Int'l Myeloma Fndtn

Multiple myeloma is a cancer of the bone marrow plasma cells -- white blood cells that make antibodies. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called "multiple" because there are frequently multiple patches or areas in bone where it grows. It can appear as both a tumor and/or an area of bone loss, and it

Category:  Cancer Go Health

Cancer Prevention in the News Int Myeloma Fn

Cancer prevention back in the news. At the recent American Society of Clinical Oncology (ASCO) meeting in Chicago, the idea of preventing the progression of high-risk smoldering multiple myeloma to active myeloma using lenalidomide was a topic of active discussion. In this study that was presented at ASCO, the onset of active disease was

Category:  Cancer Go Health

Cancer Drug Costs Int'l Myeloma Foundation

This past weekend, "60 Minutes" focused on the high cost of cancer drugs. Although the discussion centered on treatments for colon cancer and chronic myelogenous leukemia, it is an across-the-board problem. Lesley Stahl interviewed experts at Memorial Sloan Kettering Cancer Center about the very high cost--$11,000 a month--for a new drug, Zaltrap, to treat colon cancer, versus $5,000 a …

Category:  Cancer Go Health

IMWG Cancer Summit International Myeloma Foundation

The International Myeloma Working Group Summit is held annually each June, between two of the year’s largest cancer conferences, the American Society of Clinical Oncology (ASCO) in Chicago and the European Hematology Association (EHA).

Category:  Cancer Go Health

Types of Multiple Myeloma International Myeloma Foundation

Multiple myeloma has different types and subtypes. These types are based on the immunoglobulin (protein) produced by the myeloma cell. The various immunoglobulins have different functions in the body. Each immunoglobulin is made up of two heavy chains and two light chains. The five types of heavy protein chains are G, A, D, E, and M. The two types of light protein chains are kappa …

Category:  Cancer Go Health

Cancer News and Events International Myeloma Foundation

Follow the most up-to-date cancer news and events for the multiple myeloma community. Blogs, videos and a calendar of upcoming events hosted by the IMF.

Category:  Cancer Go Health

Legal Assistance for Cancer Patients Int'l Myeloma

Cancer Legal Resource Center (CLRC) The CLRC is a national, joint program of the Disability Rights Legal Center and Loyola Law School Los Angeles. It provides free information and resources on cancer-related legal issues to cancer survivors, caregivers, health care professionals, employers, and others coping with cancer.

Category:  Cancer Go Health

What Are MGUS, Smoldering and Active Myeloma

Myeloma is a cancer of the plasma cells. Plasma cells are white blood cells that make antibodies. In medical terms, these antibodies are complex proteins called "immunoglobulins." They fight foreign substances such as bacteria and viruses. Myeloma cells, unlike healthy plasma cells, cannot make functioning antibodies.

Category:  Cancer Go Health

Rene Hicks International Myeloma Foundation

With Cancer – the Sequel, I have to sit in a room with other cancer patients, wait for the nurse to poke around to find a usable vein so I can be hooked up to an IV, spend up to 3 hours getting infusions, and now I’m prepping for a bone marrow transplant. After which, I could go on maintenance with more oral chemotherapy treatment.

Category:  Cancer Go Health

Cancer Articles and Journals Int'l Myeloma Foundation

Cancer articles, journals and other publications for patients, caregivers and healthcare professionals. Download or request printed copies, free of charge.

Category:  Cancer Go Health

How to Treat Relapsed/Refractory Multiple Myeloma in 2020

Melflufen is a highly lipophilic alkylating peptide, belonging to the novel class of Peptidase Enhanced Compounds Intracellular amino-peptidases that are overexpressed in most malignant cells, will rapidly cleavemelflufen releasing the hydrophilic, active alkylating metabolite

Category:  Cancer Go Health

Multiple Myeloma in Asia An Increasing Issue

Multiple myeloma (MM) is one of the most common hematologic malignancies, with 114,252 new cases and 80,119 deaths worldwide annually in 2012, comprising 0.8% and 1% of all cancers, respectively[1]. Its incidence is known to vary by ethnicity, with Asians showing a relatively lower incidence than Caucasians by IARC data as well as US SEER data even within a country. [1] Although the incidence

Category:  Cancer Go Health

What Is a Clinical Trial International Myeloma Foundation

At some point in the care continuum, cancer clinical trials can be a treatment option for many patients. Clinical research in multiple myeloma has become a robust field with the National Cancer Institute (NCI) website cancer.gov listing more than 1,000 clinical trials.. A clinical trial is a research study of new treatment that involves patients as participants.

Category:  Cancer Go Health

Multiple Myeloma X Ray, Imaging Studies The IMF

Bone disease is a common symptom of multiple myeloma: 70%–80% of patients are found to have bone disease at diagnosis. Imaging studies that assess the status of a patient's bones and/or bone marrow at diagnosis and relapse are: X-rays CT scans MRI studies PET scans PET/CT scans You can learn more about each of these imaging studies below: X-rays X-rays are the oldest …

Category:  Cancer Go Health

Blood Cancer Awareness Month Int Myeloma Fn

Blood Cancer Awareness Month 2020. This September, the International Myeloma Foundation (IMF) asks you to take part in a social media campaign to raise awareness about blood cancers, specifically multiple myeloma, and focus on the racial disparities in myeloma care. Download a graphic from this page by right-clicking on that graphic.

Category:  Blood cancer Go Health

17p deletion International Myeloma Foundation

In this week's video, Dr. Brian G.M. Durie discusses what the deletion of chromosome 17 means to myeloma patients. Bottom Line: Chromosome 17 deletion could mean you need extra care and treatment. If you have a question that you’d like to suggest for a future episode of Ask Dr. Durie, please submit it to [email protected]org.

Category:  Cancer Go Health

Myeloma News July 3, 2019 Int'l Myeloma Fndtn

Cancer Drug Parity Discussed at Senate Committee Hearing. On June 26, 2019, the Cancer Drug Parity Act was discussed during the Senate Health, Education, Labor, & Pensions (HELP) Committee markup on S. 1895, the Lower Health Care Costs Act. Before the hearing, the IMF provided the committee with a comment letter on the Lower Health Care Costs Act.

Category:  Cancer Go Health

Precision Oncology & Cancer Moonshot Int’l Myeloma Fn

There have been recent commentaries on the prospects and potential for both what is called "precision oncology" and Vice President Joe Biden's Cancer Moonshot program. Although I have discussed both in the past, the current news, writes Dr. Vinay Prasad in the journal Nature, is quite “sobering.” The news is sobering because the hype and expectations are way beyond the truth.

Category:  Cancer Go Health

ASH2014: Pomalidomide/bortezomib/dex The IMF

Dr. Jeffrey Zonder (Karmanos Cancer Institute, Wayne State University, Detroit, Michigan) discusses results from a phase I clinical trial of pomalidomide (Pomalyst/ Imnovid), bortezomib (Velcade), and dexamethasone as initial treatment of AL amyloidosis and light chain deposition disease. These phase I study results were presented at the 56th American Society of Hematology (ASH) Annual Meeting.

Category:  Cancer Go Health

Call the Multiple Myeloma Cancer Hotline IMF InfoLine

Call us. We’re here for you. The InfoLine is the IMF's multiple myeloma cancer information line. COVID-19 Advisory. With a focus on the health and well-being of our staff given the growing concerns over the COVID-19 (coronavirus), the IMF’s physical offices will close on Friday, March 13, with a …

Category:  Cancer Go Health

UC Cancer Consortium & Medical Tourism Int Myeloma Fn

The ongoing need for new cancer treatments prompted the University of California to launch a new cancer consortium. It was announced this week that the university’s five cancer centers (San Francisco, Irvine, San Diego, Los Angeles, and Davis) will align to battle the disease, which is poised to become the leading cause of death in the state

Category:  Cancer Go Health

International Myeloma Foundation Launches “M-Power

Multiple myeloma is a cancer of the blood plasma cells that will strike more than 30,000 adults this year, according to the Centers for Disease Control. The disease is the most common blood cancer in African Americans and is more than twice as common in …

Category:  Cancer Go Health

Monthly PMMNG Meetings Philadelphia

As you also may know, Christina is an expert on health insurance for cancer patients so bring your questions for our discussion.To prepare for the meeting and to help you organize your questions, please take a few minutes to review the webinars that Christina …

Category:  Cancer Go Health

Individual Cancer Treatment Int’l Myeloma Fn

The initial cost of treating myeloma is $10,000 to $15,000 per month, which falls steadily in the next 18 months. The average monthly cost is around $7,000 per month for Revlimid®-based regimens and a little higher, around $10,000 per month, for bortezomib-based regimens. The only part of that is the drug costs.

Category:  Cancer Go Health

cancercare Philadelphia

Understanding Their Role in Cancer Treatments - Current and Future Perspectives; CancerCare: Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation - New Treatment Approaches.

Category:  Cancer Go Health

Blood Tests to Assess Kidney Function int Myeloma Fn

The International Myeloma Working Group (IMWG) and National Comprehensive Cancer Network (NCCN) both recommend kidney function tests for multiple myeloma patients. Learn about each of these tests and how they are used to diagnose and monitor your disease and kidney function.

Category:  Cancer Go Health

New Strategies for Multiple Myeloma Care: Case Studies for

As part of the Oncology Nurses Society’s ONS Bridge Event, the International Myeloma Foundation hosted a virtual symposium New Strategies for Multiple Myeloma Care: Case Studies for Nurses in September, 2020. Four highly experienced nurses shared …

Category:  Cancer Go Health

Early Treatment for High-Risk Smoldering MM: Going for a …

Mateos Blood Cancer J. 2020;10:102. Risk . Stratification . Groups. Hazard Ratio (95% CI) Versus Low -risk group (censored 2 year) 0-4: Reference. 5-8: 7.56 (3.77 to 15.2) 9-12: 17.3 (8.63 to 34.8) > 12: 31.9 (15.4 to 66.3) Total Risk Score: 2-year Progression . n (%) 0-4. 9 / 241 (3.7%) 5-8. 67 / 264 (25.4%) 9-12. 65 / 133 (48.9%) > 12. 37

Category:  Cancer Go Health

Cancer Cases Among 9/11 Early Responders Continue to Grow

The chemical is a known cancer-causing agent which, in the 9/11 setting, is now clearly linked to the causation of myeloma. Cancer patients--including those with myeloma--can receive awards through the September 11 th Victim Compensation Fund (VCF). Although patients are obviously grateful to have a VCF available to help cover lost earnings

Category:  Cancer Go Health

Myeloma News April 5, 2018 Int'l Myeloma Fndation

The April 5, 2018 issue covers evidence linking toxic chemicals to cancer, the 10th annual Miles for Myeloma, 9/11 toxic exposures, and more.

Category:  Cancer Go Health

Clinical Trial Glossary International Myeloma Foundation

Patients in phase I trials generally have advanced cancer that is refractory to all standard treatment. In a typical phase I trial, successive groups (“cohorts”) of three to six patients are given the treatment. All patients in a cohort get the same dose. The first cohort typically gets a very low dose, and the dose is raised in each

Category:  Cancer Go Health

Help for Cancer Patients Download Myeloma Tip Cards

Designed to serve as consistent references in a concise manner, the IMF’s Tip Cards cover key topics, including treatment and care issues of interest to patients and caregivers. All of the Tip cards below can be downloaded, free of charge. Pagination. Current page.

Category:  Cancer Go Health